Elan to create spinoff discovery science company

Elan's board of directors has approved the spinoff of the discovery science and Neotope Biosciences from the company.

13th August, 2012
Tysabri, a key Elan treatment

Elan's board of directors has approved the spin-off of the discovery science and Neotope Biosciences from the company.

According to a statement from the company, completion of this transaction will create two "independent, highly focused, public companies that will enable investors to align timelines, risk and returns in order to best achieve their investment objectives".

The two companies will be Elan Corporation and Neotape Biosciences.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago